Posts Tagged ‘Homozygous familial hypercholesterolemia’

January 29th, 2013

FDA Approves Mipomersen for Homozygous Familial Hypercholesterolemia

The FDA said today that it had granted approval to the novel cholesterol-lowering drug mipomersen sodium for use as an adjunct to diet and drug therapy in patients with homozygous hypercholesterolemia. The drug, which was developed by Isis Pharmaceuticals, will be marketed under the brand name of Kynamro by Genzyme. Kynamro was approved as an orphan drug, which the […]